Table 1.

Baseline cohort characteristics

Increased risk for hypoglycemia	SAP with automated insulin suspension (n = 46)	CSII (n = 49)
Age (years)	17.4 ± 10.6	19.7 ± 12.9
Male (%)	56.5%	42.9%
Duration of diabetes (years)	9.8 ± 7.4	12.1 ± 10.0
HbA1c, % (mmol/mol)	7.6% (60)	7.4% (57)
Hypoglycemia unawareness score	5.9 ± 1.5	6.4 ± 1.5

Uncontrolled HbA1c at baseline	Overall
Age (years)	46 ± 17
Male (%)	55.7%
Duration of diabetes (years)	24 ± 15
HbA1c,  % (mmol/mol)	7.92 (63.14)

Data are presented as the mean ± standard deviation, unless indicated otherwise

CSII continuous subcutaneous insulin infusion, SAP sensor-augmented pump therapy, HbA1c glycated hemoglobin